AnaptysBio, Inc. (ANAB)

69.48 +2.72 (+4.07%) USD  |  NASDAQ  |  May 04, 10:25
More

AnaptysBio Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for ANAB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Nektar Therapeutics Upgrade
Rigel Pharmaceuticals, Inc. Upgrade
Axsome Therapeutics, Inc. Upgrade